Kanghong pharmaceutical received the regulatory letter: it failed to make the performance forecast before January 31, 2021 as required
Kanghong pharmaceutical announced that the Shenzhen Stock Exchange issued a regulatory letter because the company failed to make a performance forecast before January 31, 2021 as required.
This text is a result of machine translation.
Related companies：
Briefing Feb 07, 2022 03:40 PM
· Consumer Staples
"Bing dwen dwen" has 29 licensed manufacturers, most of which have access threshold 20 million.
In-depth
Nov 16, 2022 05:19 PM
Nov 07, 2022 04:27 PM
Aug 29, 2022 05:45 PM
Apr 25, 2022 01:02 PM
Briefing Nov 18, 2021 08:39 AM
· Consumer Staples
CSC: the short-term growth of sportswear is under pressure, and the long-term boom continues
Briefing Sep 23, 2021 01:10 PM
· Consumer Staples
Hong Kong sporting goods stocks continued to decline
Briefing Sep 02, 2021 03:05 PM
· Consumer Staples
The sports sector of Hong Kong stocks fell, and Li Ning fell nearly 5%
Consumer Staples
Ctrip Group Reports 2023Q3 Earnings: Net Operating Income of CNY 13.7 Billion, Up 99% YoY
After the epidemic, the recovery of the tourism industry under globalization trends has been effective, and the industry continues to strengthen technological innovation and sustainable development in the future.
Nov 21, 2023 03:48 PM
Briefing Jul 28, 2021 10:55 AM
· Consumer Staples
Hong Kong sporting goods stocks rose intraday, with Li Ning up more than 11%, Anta Sports up more than 7% and Tebu international up nearly 7%.
Briefing Jul 15, 2021 10:03 AM
· Consumer Staples
Hong Kong Sports Goods stocks were strong, with Tebu international up 6.43%
See more
Read next
Insight
In-depth
Insight
In-depth
Insight
In-depth
Insight
In-depth